ProfessorBrian Robertson

The aim of our research is to understand the host-pathogen interactions underlying the complex biology of tuberculosis infection, and to exploit this understanding for development of improved tools for disease control. We are investigating different ways to deliver anti-TB drugs, the potential of anti-microbial peptides, innate immune responses, and host-directed therapies to improve TB treatment. We are also analysing how mycobacteria grow and divide, using microfluidics-based single cell analysis and time-lapse video microscopy.

I am a founder member of the Centre for Bacterial Resistance Biology, and Editor-in-Chief of the journal Tuberculosis.